Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma

NCT06390956 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.

NCT NCT06390956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06390956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma
Lead sponsor
University of Utah
Phase
Phase 2
Overall status
Recruiting
Start date
February 20, 2025
Completion date
December 31, 2032
Enrollment
23 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

marginal zone lymphoma